PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.\', \'Centre for Inflammation Research, Queens Medical Research Institute, University of Edinburgh, Edinburgh, UK.\', \'Center for Clinical Brain Sciences, Chancellors Building, University of Edinburgh, Edinburgh, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1177/24725552211019405
?:doi
?:hasPublicationType
?:journal
  • SLAS discovery : advancing life sciences R & D
is ?:pmid of
?:pmid
?:pmid
  • 34078171
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Application of a High-Content Screening Assay Utilizing Primary Human Lung Fibroblasts to Identify Antifibrotic Drugs for Rapid Repurposing in COVID-19 Patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34078171>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34078171>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all